| Clostridiales incertae sedis
Short-Chain Fatty Acid Production: Anaerostipes bacteria, like other members of the Lachnospiraceae family, are involved in the fermentation of dietary fibers and complex carbohydrates in the colon. This fermentation process produces short-chain fatty acids (SCFAs), such as butyrate. SCFAs play a role in gut health by providing an energy source for colonocytes, maintaining gut barrier function, and exhibiting anti-inflammatory effects.
Metabolism and Nutrient Utilization: Anaerostipes species are thought to be involved in the breakdown of complex carbohydrates, contributing to the digestion process in the gut. They can metabolize certain substrates, and their presence may influence the overall metabolism of the gut microbiota.
Association with Diet: The abundance of Anaerostipes in the gut microbiota can be influenced by dietary factors. Diets rich in fiber and complex carbohydrates may support the growth of Anaerostipes and other fiber-degrading bacteria.
Butyrate Production: Some species within the genus Anaerostipes are known for their ability to produce butyrate, a short-chain fatty acid that has been associated with various health benefits. Butyrate is considered essential for the health of the colonic epithelium, and it has anti-inflammatory properties.
Gut Microbiota Composition: Anaerostipes contributes to the overall diversity and composition of the gut microbiota. The balance and diversity of the gut microbiota are increasingly recognized as important factors in maintaining gut and overall health.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 6.66 | 0 | 0 | 10 | 128000 | 0 | 39904 | 7780.8 | 2196 | 16389.2 | 0 | 13916 | 0 %ile | 100 %ile |
biomesight | 84.45 | 0 | 200 | 10 | 2520 | 0 | 2123 | 300 | 80 | 930.3 | 0 | 380 | 3.7 %ile | 98.1 %ile |
thorne | 100 | 554 | 6300 | 0 | 4332 | 2043 | 1650 | 1167.7 | 1112 | 2928 | 0 %ile | 100 %ile | ||
thryve | 99.91 | 433 | 32944 | 963 | 26942 | 0 | 65561 | 16724.1 | 8604 | 24916.8 | 0 | 32738 | 10.3 %ile | 91.4 %ile |
ubiome | 96.96 | 258 | 7448 | 376 | 6714 | 0 | 25254 | 4789.3 | 2467 | 10441.2 | 0 | 8039 | 6 %ile | 90.2 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
AmericanGut | 66.667 % | 0.048 % | 0.033 % | 10.0 | 15 |
BiomeSight | 89.944 % | 0.027 % | 0.084 % | 2576.0 | 2864 |
BiomeSightRdp | 90.625 % | 0.69 % | 1.385 % | 29.0 | 32 |
bugspeak | 100 % | 0.668 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.222 % | 0.062 % | 3.0 | 3 |
CosmosId | 100 % | 0.601 % | 0.765 % | 32.0 | 32 |
custom | 38.983 % | 0.511 % | 0.906 % | 23.0 | 59 |
es-xenogene | 62.069 % | 0.22 % | 0.175 % | 18.0 | 29 |
Medivere | 100 % | 0.064 % | 0.065 % | 7.0 | 7 |
Microba | 35.714 % | 1.594 % | 3.984 % | 10.0 | 28 |
Microba1 | 100 % | 0.79 % | % | 1.0 | 1 |
SequentiaBiotech | 97.222 % | 0.885 % | 0.888 % | 35.0 | 36 |
Thorne | 77.778 % | 0.151 % | 0.108 % | 70.0 | 90 |
Thryve | 99.928 % | 1.775 % | 2.575 % | 1382.0 | 1383 |
Tiny | 100 % | 11.643 % | % | 1.0 | 1 |
uBiome | 96.591 % | 0.479 % | 1.044 % | 765.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.